Healthcare Services Q2 revenue beats estimates, announces $50 mln buyback

Healthcare Services

23/07/2025 12:09

Overview

Healthcare Services Q2 revenue rises 7.6%, beating analyst expectations

Net income impacted by Genesis restructuring, resulting in a loss of $32.4 mln

Company announces $50 mln share repurchase plan over next 12 months

Outlook

Healthcare Services Group raises 2025 cash flow forecast to $70-85 mln, excluding payroll accrual changes

Company reiterates 2025 mid-single digit revenue growth expectations

Healthcare Services Group aims to manage 2025 service costs in 86% range

Company plans $50 mln share repurchase over next 12 months

Result Drivers

ORGANIC GROWTH - New client wins and higher retention drove organic growth, per CEO Ted Wahl

GENESIS IMPACT - $61.2 mln non-cash charge from Genesis restructuring impacted net income

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$458.49 mln
$450.80 mln (5 Analysts)
Q2 EPS
-$0.44
Q2 Net Income
-$32.37 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the business support services peer group is "buy."

Wall Street's median 12-month price target for Healthcare Services Group Inc is $15.00, about 13% above its July 22 closing price of $13.05

The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release: ID:nBwblnjZMa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)